BURR RIDGE, Ill. , Aug. 26, 2024 /PRNewswire/ -- SkinCure Oncology , the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer, today announced the publication of a new study that underscores the value of performing full dermal visualization (FDV) via high-resolution dermal ultrasound (HRDUS) prior to every fraction during treatment of nonmelanoma skin cancer (NMSC) with image-guided superficial radiation therapy (Image-Guided SRT).
The study, "Understanding the Importance of Daily Imaging in the Treatment of Non-Melanoma Skin Cancer with Image-Guided Superficial Radiation Therapy," was published in the peer-reviewed, international skin science journal Dermato . The study was authored by Jeffrey Stricker , DO, MBA, CPE, FCAP, of Dermatology Specialists of Alabama , Huntsville ; Janine Hopkins , MD, FAAD of Hopkins Dermatology, Monroe, Louisiana and Southlake, Texas ; Aaron Farberg , MD of Bare Dermatology, Dallas, Texas ; and Peyton Harris of the College of Medicine, Texas A&M University, College Station . The authors report, "Increasing and decreasing tumor depth measurements during Image-Guided SRT inform[s] dermatologists when adaptive changes in energy (kV), TDF, and dose will result in more efficacy and less toxicity, respectively.
" The study involved retrospective review of the medical records of 883 patients with 1,507 cases of NMS.